Call for Abstract

28th International Conference on Diabetes, Endocrinology and Healthcare, will be organized around the theme “Innovation in Diabetes, The Most Cutting-Edge technologies and latest research”

Herbal Diabetes 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Herbal Diabetes 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

The endocrine system regulates bodily functions through hormones produced by glands such as the thyroid and adrenal glands. Disorders may arise from hormone imbalances, leading to conditions like diabetes, hypothyroidism, or Cushing's syndrome. These disorders can affect metabolism, growth, and various physiological processes, requiring medical intervention for management.

There are three main types of diabetes: Type 1, an autoimmune condition where the body doesn't produce insulin; Type 2, characterized by insulin resistance; and gestational diabetes, occurring during pregnancy. Type 1 requires insulin, while Type 2 may be managed with lifestyle changes, medication, or insulin depending on severity.

Diabetes mellitus is a chronic metabolic disorder characterized by high blood sugar levels. It results from insufficient insulin production (Type 1) or ineffective use of insulin (Type 2). Symptoms include increased thirst, frequent urination, and unexplained weight loss. Proper management involves lifestyle changes, medication, and monitoring blood glucose levels.

Diabetes symptoms include excessive thirst, frequent urination, fatigue, and unexplained weight loss. Complications may involve cardiovascular issues, kidney damage, nerve damage leading to neuropathy, vision problems, and slow wound healing. Timely diagnosis and management of diabetes through lifestyle modifications and medications can help prevent or mitigate these complications.

Obesity is a major risk factor for type 2 diabetes, influencing metabolism. Excess adipose tissue contributes to insulin resistance, impairing glucose regulation. Adipose cells release inflammatory substances, further disrupting metabolic balance. Weight loss and physical activity can improve insulin sensitivity, aiding in diabetes prevention and management.

Diabetic retinopathy is a complication of diabetes affecting the eyes. Prolonged high blood sugar damages blood vessels in the retina, leading to vision impairment or blindness. Early stages may be asymptomatic, making regular eye exams essential for timely detection and intervention, including laser therapy or surgery to prevent progression.

Diabetic nephropathy is a kidney complication resulting from diabetes. Prolonged high blood sugar damages the kidneys' filtering units, leading to protein leakage and impaired function. It may progress to end-stage renal disease. Strict blood sugar control, blood pressure management, and lifestyle changes are crucial in preventing and managing diabetic nephropathy.

Diabetic nutrition focuses on maintaining stable blood sugar levels through a balanced diet. Emphasizing complex carbohydrates, fiber, lean proteins, and healthy fats helps regulate glucose. Monitoring portion sizes, choosing low-glycemic foods, and consistent meal timing are vital components, promoting overall health and effective diabetes management.

Advancements in diabetes care include continuous glucose monitoring, insulin pumps, and artificial pancreas systems. Continuous glucose monitors provide real-time data, enhancing blood sugar control. Insulin pumps offer precise insulin delivery, while artificial pancreas systems automate insulin release, improving glycemic management. These technologies signify significant progress in tailoring treatments for better diabetes outcomes.

Diabetes mellitus arises from multifactorial causes. Type 1 diabetes results from autoimmune destruction of insulin-producing pancreatic cells. Type 2 diabetes is linked to genetic factors, insulin resistance, and lifestyle choices. Gestational diabetes occurs during pregnancy due to hormonal changes. Understanding and addressing these diverse etiological factors are crucial for effective prevention and management.

Blood glucose dynamics in diabetes involve maintaining optimal levels for energy. Regular monitoring, using devices like glucometers or continuous glucose monitors, helps individuals track fluctuations. This data informs medication adjustments, dietary choices, and lifestyle modifications, enabling personalized management to achieve stable blood glucose levels and prevent complications.

Emerging treatments and technologies in healthcare include gene therapy, CRISPR-based interventions, personalized medicine, and advanced biologics. Artificial intelligence aids diagnostics and drug discovery. Immunotherapies show promise in cancer treatment. These innovations signify a transformative era, offering more precise, effective, and individualized approaches to address complex medical challenges.

For poorly controlled diabetes, an individualized approach involves lifestyle changes, intensified medication regimens, and regular monitoring. A comprehensive strategy includes dietary modifications, increased physical activity, and potential insulin adjustments. Collaborative efforts between patients and healthcare providers are crucial to tailor interventions and achieve better glycemic control, mitigating complications.

Prediabetes signifies elevated blood sugar levels, indicating a high risk of developing diabetes. Without intervention, it can progress to Type 2 diabetes. Late-stage complicated diabetes involves severe complications like neuropathy, nephropathy, and retinopathy. Regular screenings, lifestyle changes, and timely medical management are vital in preventing progression and complications.

Clinical care and education in healthcare involve providing expert medical attention and imparting knowledge to patients. This comprehensive approach encompasses disease prevention, diagnostics, treatment, and ongoing education for patients and their families. Integrating these elements enhances patient understanding, engagement, and outcomes, fostering a collaborative healthcare partnership.

COVID-19 can exacerbate diabetes symptoms and increase the risk of severe outcomes. Post-COVID diabetes, a potential complication, may arise due to viral impact on pancreatic cells. Monitoring blood sugar levels, vaccination, and post-recovery diabetes screening are crucial to manage the interplay between COVID-19 and diabetes effectively.

Diabetes significantly impacts cardiovascular health. It raises the risk of heart disease and stroke due to factors like high blood sugar, inflammation, and lipid abnormalities. Collaborative cardiology care involves managing blood pressure, cholesterol, and blood sugar levels to prevent and address cardiovascular complications in individuals with diabetes.

New therapies in healthcare present both risks and benefits. Benefits may include improved efficacy, reduced side effects, and enhanced patient outcomes. Risks encompass potential unknown long-term effects, unforeseen complications, and accessibility challenges. Rigorous evaluation, ongoing monitoring, and ethical considerations are crucial in assessing and balancing these factors.

Transplantation involves replacing a damaged organ with a healthy one, such as a pancreas for diabetes treatment. Artificial pancreas systems combine continuous glucose monitoring with automated insulin delivery. While transplantation provides a long-term solution, artificial pancreas technology offers a non-invasive approach, both aiming to improve glycemic control in diabetes.

Insulin resistance is a condition where cells respond poorly to insulin, leading to elevated blood sugar levels. Insulinotherapy involves administering insulin to manage diabetes. Tailoring insulin doses, combining therapies, and addressing lifestyle factors are essential in mitigating insulin resistance and achieving optimal glycemic control for individuals with diabetes.

Diabetes and mental health are intertwined. Managing a chronic condition like diabetes can impact mental well-being, leading to stress and depression. Conversely, mental health issues may affect self-care. Integrating psychological support, promoting coping strategies, and fostering a holistic healthcare approach are crucial for comprehensive diabetes management.

Artificial Intelligence (AI) holds immense potential in revolutionizing diabetes care. AI applications can analyze vast datasets for personalized treatment plans, predict complications, and improve glucose monitoring. Automated insulin delivery systems and smart health devices driven by AI contribute to more efficient, precise, and patient-centric diabetes management, heralding a promising future.

The global diabetes market encompasses a dynamic landscape of pharmaceuticals, devices, and technologies aimed at managing and treating diabetes. It includes insulin therapies, oral antidiabetic drugs, glucose monitoring devices, and innovative technologies. Continuous research and development address the evolving needs of the growing global diabetic population, fostering market growth and advancements.

Healthcare systems' effectiveness in providing access to allopathic diabetes care varies globally. Disparities in resources, education, and infrastructure impact accessibility. Improving healthcare infrastructure, promoting education, and ensuring affordability are essential for enhancing global access to allopathic diabetes care, addressing the complex challenges associated with this chronic condition.

Management of diabetic complications involves a multi-faceted approach, including regular monitoring, lifestyle modifications, medication adherence, and addressing risk factors. Preventive measures, such as blood pressure and cholesterol control, along with targeted interventions for complications like neuropathy and retinopathy, are vital to mitigate the impact and enhance the overall well-being of individuals with diabetes.

Nanotechnology in diabetes treatment involves the application of tiny particles for targeted drug delivery, glucose sensing, and tissue regeneration. Nano-sized materials enhance therapeutic precision, reduce side effects, and improve treatment efficacy. Innovations in nanomedicine hold promise for revolutionizing diabetes management by advancing personalized and minimally invasive approaches.